Today Pfizer / BioNTech SE announced positive topline results from COVID-19 vaccine trial in children 5 to 11 years old via press release (still waiting for full report and data).
Highlights given in Press Release of Phase 2/3 trial (link in below):
Category: COVID-19 Pandemic
COVID-19 vaccine or testing requirement coming soon at your company?
Recent news emerged that President Biden will be implementing a requirement for large businesses (>100 employees) to have employees vaccinated for COVID-19 or undergo weekly testing. If weekly testing occurs, details have yet to be released to whether the employer will have to cover the cost of weekly testing or the unvaccinated employees could use the free federal sites or would have to pay out of pocket.
Are you using vaccine card or digital vaccine passport where you live?
More and more cities and regions are opting into using technology with vaccine passports. British Columbia, Canada just released its new program requiring people to show in order to enter non-essential business activities. There are plans in Alberta, Canada to create a proof of vaccination card and QR code coming soon in upcoming weeks, as well.
A constant message: the pandemic is not over until it is over everywhere.
United States is first country to hit 40 million coronavirus cases. The next country near that mark is India with 33 million coronavirus cases, then followed by Brazil with 20 million coronavirus cases.
Have you considered moving during the COVID-19 pandemic due to your local government’s response and/or local community’s caseload? Will FDA’s full approval of the Pfizer / BioNTech SE vaccine play a factor in the shift of US?
Monday morning and news arrived that FDA fully approves Pfizer / BioNTech SE Coronavirus Vaccine as the first COVID-19 vaccine for prevention of #COVID19 disease in 16 years of age and older.
COVID-19 vaccines are working to protect against death along with some protection against hospitalization and mild infections. The latter protections seem to be declining in effectiveness plus Delta variant (and Lamba variant) are some of the reasons why US announce approval of a third shot (dose) for US population at 8 months or later after receiving the first two doses of Pfizer/BioNTech SE & Moderna.
A simple mix up of ingredients for the Johnson & Johnson and AstraZeneca/University of Oxford coronavirus vaccines was said to occur at Emergent BioSolutions plant.
Categories
Covid-19 Vaccine R&D Update
A constant question to me – where are the Johnson & Johnson vaccines?
Yesterday, early phase 3 data from Oxford-AstraZeneca was published and shared about the latest clinical trial on its COVID-19 vaccine including a study conducted in United States. Post here: https://publichealthdisasters.com/2021/03/22/worlds-vaccine-found-79-percent-effective/. Now a possible rebuke?